I hate seeing people throw out the baby with the...

I hate seeing people throw out the baby with the bathwater.

Nothing has changed!

The directors simply want to rollover their ZEPO options, which they believed they were entitled to back in 2018 and no doubt believe that they have unfairly missed out on them because of Covid.

Me on the other hand don't understand what the shareholders back in 2018 were thinking - it was a ridiculously generous incentive. Though I note that there were fewer and very large shareholders, so perhaps it was negotiated.

In my opinion the ZEPO options should be voted down and this threat to significantly dilute the shareholdings closed off. This said, I would be more than happy to vote for director options next year, with an exercise price target above the prevailing; and, no non-recourse loans attached to fund it.

The total commitment pipeline of $13 million was at 27 January. Since then we have had -

1. Pyne appointment.
2. AI rollout.
3. Homeland Security Cooperative Agreement.
4. 'High profile government customer' follow-up order of of $1,000,000.

All this in less than 8 weeks.

Conservatively it looks like we are moving forward at $1,000,000 revenue per month, which is a solid improvement from where we were 12 months ago. And, at the frequency of announcements and with the customer base we have established, I am betting we are at $2,000,000 per month by year end. (Fingers crossed).

So to others - remember shareholders are the DRO owners. If you don't like the management incentive package - vote 'no'. At least this way management know you care. If you sell - nobody cares.

SK.